Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
What the clinical trial data shows Weight loss SURMOUNT-5 SURMOUNT-5 enrolled 751 adults with obesity but without type 2 diabetes and assigned them to the maximum tolerated dose of either tirzepatide (10 mg or 15 mg) or semaglutide (1.7 mg or 2.4 mg) for 72 weeks
The business was established within a foundation structure, in line with the agreement with the researchers in Canada
Patients may still be able to receive compounded GLP-1s through 503A compounding pharmacies, and consider legitimate alternatives for weight loss
Online clinics and telehealth providers now offer these medications virtually, sometimes with minimal screening for psychiatric history
Ozempic delivers major weight loss in adults over 65, study finds Date: May 11, 2026 Source: European Association for the Study of Obesity Summary: A major new analysis suggests semaglutide (Ozempic, Wegovy) works remarkably well in adults over 65, helping many lose substantial amounts of weight while improving heart and metabolic health
US$ 26.37
US$ 26.64
US$ 21.55
US$ 20.68
US$ 29.33
US$ 24.52
US$ 28.12
